~~<i id='76EFAA30F5'><strike id='76EFAA30F5'><tt id='76EFAA30F5'><pre id='76EFAA30F5'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：fashion 2025-09-06 09:28:48 Page View：94

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： UnitedHealth argues against case alleging wrongful AI care denials
Next article： New air purifier tech could be key to improving indoor air quality

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

Trans patients at the end of life deserve respect and dignity

JohnMoore/GettyImagesIntheUnitedStates,morethan1.6millionpeopleidentifyastransgender.Ofthese,moretha

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Vivek Ramaswamy made waves in the debate, much as in biotech

BusinessmanVivekRamaswamyandformerU.N.AmbassadorNikkiHaleyAPPhoto/MorryGashTheyoungestcandidateonWed